Risk of thrombotic events after inpatient intravenous immunoglobulin or plasma exchange for neurologic disease: A case-crossover study
- 1 September 2020
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 62 (3), 327-332
- https://doi.org/10.1002/mus.26884
Abstract
Introduction Our aim in this study was to determine whether intravenous immunoglobulin (IVIg) or plasma exchange (PLEx) for treatment of neurologic disease is a trigger for thrombotic events. Methods Using administrative data from 2005 to 2014, we identified index admissions for thrombotic events. We performed case-crossover analyses for these admissions with previous admissions for neurologic disease with IVIg or PLEx using exposure periods of between 7 and 120 days. Results We identified 1.9 million admissions for venous thrombosis embolism, myocardial infarction, or acute ischemic stroke. The odds ratio for venous thrombosis embolism within a 30-day window after exposure to IVIg was 3.33 (1.34-8.30, P = .0097) and for PLEx was 4.29 (1.88-9.76, P = .0005). Myocardial infarction and acute ischemic stroke admissions were not associated with exposure to either therapy. Discussion Patients admitted for venous thrombosis embolism (but not acute ischemic stroke or myocardial infarction) were more likely exposed to either IVIg or PLEx during previous admission for neurologic disease.Funding Information
- American Academy of Neurology
This publication has 33 references indexed in Scilit:
- A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative dataPharmacoepidemiology and Drug Safety, 2012
- Hospitalization for Infection and Risk of Acute Ischemic StrokeStroke, 2011
- Complications of therapeutic plasma exchange: A prospective study of 1,727 proceduresJournal of Clinical Apheresis, 2007
- Why now? Moving from stroke risk factors to stroke triggersCurrent Opinion in Neurology, 2007
- Adverse effects of treatment with intravenous immunoglobulins for neurological diseasesZeitschrift für Neurologie, 2006
- Complications of Therapeutic Plasma Exchange: Experience With 4857 TreatmentsTherapeutic Apheresis and Dialysis, 2005
- Coding of Stroke and Stroke Risk Factors Using International Classification of Diseases , Revisions 9 and 10Stroke, 2005
- Validating Administrative Data in Stroke ResearchStroke, 2002
- Accuracy of ICD-9-CM Coding for the Identification of Patients With Acute Ischemic StrokeStroke, 1998
- Complications of plasma exchangeTransfusion, 1989